The new treatment resistant form of mood disorder, a rare but serious form of the disease, has been identified in nearly half of the 3,800 adults and children diagnosed in the U.S. as part of the National Alliance on Mental Illness survey.
The new disorder is more common in people with a history of substance abuse and anxiety disorders, according to the alliance.
Treating the new form of depressed mood can help people live longer, healthier lives, and may help others live longer.
The Alliance’s study of nearly 3,000 adults and youth found that nearly 40 percent of people with the new disorder had experienced at least one episode of depression in the past year.
The condition affects nearly half the adults and nearly one in three children.
Symptoms can include sadness, hopelessness, low energy, irritability and a loss of interest in activities.
People with the condition often are unable to function normally because of the underlying disorder.
Treatment can help to manage symptoms and reduce the chances of relapse, according a statement from the alliance’s chief medical officer, Dr. Karen Daugherty.
It can also help people with treatment resistant depressive disorder to manage their symptoms.
A recent study found that treatment resistant depressed mood is rare, but the new diagnosis is becoming more common.
The study was published online Feb. 25 in the journal Psychiatry Research.
People can be diagnosed with treatment resistance if they are at risk for a new illness, or if they have a previous history of depression.
Treatment resistant depression is the most frequent form of treatment resistant affective disorder.
About a third of adults and 40 percent to 60 percent of children have it, according the Alliance’s survey.
Treatment resistance can be treated with psychotherapy, medication or both.
Some people have a rare form of untreated treatment resistant disorder, which is rare and is often difficult to treat.
People who are treatment resistant can benefit from getting a new diagnosis and treatment, according, the alliance statement.
This new form can be difficult to diagnose.
Treatments like cognitive behavioral therapy, cognitive behavioral and family therapy can help manage symptoms.
People may be able to manage treatment resistant symptoms with medication.
The prevalence of treatment resistance can vary depending on the person and the disorder, but is higher in those with substance abuse or anxiety disorders.
It is also more common among people who are older and have experienced previous episodes of depression, the statement said.
The symptoms may include feelings of sadness, anger, anxiety, irritable mood and low energy.
Treations like cognitive behavior therapy and family and occupational therapy can also ease symptoms and help manage mood, the Alliance statement said, and can help prevent relapse.
In addition to the new disease, the new syndrome also is linked to an increase in the number of cases of autism spectrum disorder and attention deficit hyperactivity disorder.